表紙:乳腺嚢胞治療の世界市場:2022年~2029年
市場調査レポート
商品コード
1082943

乳腺嚢胞治療の世界市場:2022年~2029年

Global Breast Cyst Treatment Market - 2022-2029

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
乳腺嚢胞治療の世界市場:2022年~2029年
出版日: 2022年06月03日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の乳腺嚢胞治療の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、アンメットニーズ、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 乳腺嚢胞治療市場:調査手法・調査範囲

第2章 乳腺嚢胞治療市場:市場の定義と概要

第3章 乳腺嚢胞治療市場:エグゼクティブサマリー

第4章 乳腺嚢胞治療市場:市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 乳腺嚢胞治療市場:産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ

第6章 乳腺嚢胞治療市場:COVID-19の分析

  • COVID-19:市場への影響分析
  • COVID-19渦中の価格ダイナミクス
  • 需給スペクトル
  • パンデミック時の政府の市場関連イニシアチブ
  • 製造業者の戦略的イニシアチブ
  • 総論

第7章 乳腺嚢胞治療市場:治療タイプ別

  • 穿刺吸引生検
  • 手術
  • 放射線療法
  • ホルモン療法

第8章 乳腺嚢胞治療市場:エンドユーザー別

  • 病院
  • クリニック
  • その他

第9章 乳腺嚢胞治療市場:地域別

  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第10章 乳腺嚢胞治療市場:競合情勢

  • 主な展開・戦略
  • 企業シェア分析
  • 製品ベンチマーキング

第11章 乳腺嚢胞治療市場:企業プロファイル

  • Becton, Dickinson and Company
  • Advin Health Care
  • Swastik Enterprise
  • Argon Medical Devices, Inc.
  • SOMATEX Medical Technologies GmbH
  • Remington Medical Inc.
  • HAKKO CO., LTD.
  • BPB MEDICA

第12章 乳腺嚢胞治療市場:DataM

目次
Product Code: DMPH5389

Market Overview

The global breast cyst treatment market is growing at a high CAGR during the forecast period (2022-2029).

Inside the breast, cysts are fluid-filled sacs. They are usually cancer-free (benign). Breast cysts can be single or multiple. A breast cyst feels like a grape or a water-filled balloon most of the time, but it can also be firm.

Market Dynamics

The factors influencing the global breast cyst treatment market are the increasing research and development and the growing prevalence of breast cysts.

The increasing research and development are expected to drive the market growth

Cysts appear to form due to fibrosis in the development of breast tissue and subsequent failure of the lobule and terminal ductule formation process. The physical mechanism is that fibrosis causes epithelial thickening, which causes the developing lobule to be involute early in its development. This causes the surrounding stroma to vanish and the adjoining ductule to collapse, resulting in an abnormal epithelial-lined fold that becomes completely walled off. Epithelial acinar secretions dilate the epithelial fold, transforming it into a self-contained fluid-filled cavity. Moreover, many studies show a high lifetime prevalence of fibrocystic breast disease in women. Over 70% of all women experience fibrocystic changes at some point in their lives, with 20% of these women becoming symptomatic and 10% -30% developing sclerosing adenosis. A palpable breast cyst is estimated to affect 7% of all women in the United States at some point in their lives. Breast cysts are most common in women aged 30 to 50. During these years, the incidence of cyst development rises and then falls dramatically. Most benign cysts disappear, and new cysts stop developing a year after menopause, as cyst development is linked to hormone levels in the body.

Limitations associated with breast cyst treatment are expected to hamper the market growth

The risks associated with Fine Needle Aspiration are minimal. The injection site has a small chance of bleeding and infection. The patient may be sore for a day or two after the procedure, and mild bruising and swelling may occur. Another disadvantage of fine needle aspiration is that the needle may miss a tumor and instead take a sample of healthy cells.

If this occurs, the biopsy will show that cancer does not exist when it does. A false negative result causes a delay in diagnosis. Fine needle aspirations of palpable lumps have a 2-4 percent low false-negative rate.

COVID-19 Impact Analysis

The market has suffered a minor setback due to the COVID-19 outbreak, owing to delays in diagnosis, drug shortages, and a lack of healthcare professionals. According to an article published in the JAMA Network in August 2020, between March 1, 2020, and April 18, 2020, there was a significant decrease in breast cancer treatment and diagnosis in the United States (by as much as 51.8 percent). As a result, the delay in diagnosing breast cancer has impacted treatment. In its early stages, the COVID-19 pandemic has had a negative impact on the breast cyst treatment market. However, as treatments are resumed worldwide, the market is expected to gain traction in the coming years.

Segment Analysis

Fine-needle aspiration segment is expected to dominate the market growth

If all the fluid in the cyst can be removed during the procedure, fine-needle aspiration can be used to diagnose and treat a breast cyst, and breast lump and symptoms disappear. However, some breast cysts may require more than one drainage procedure. Cysts that recur or form new cysts are common. If a breast cyst persists for two to three menstrual cycles and grows, it should be treated. A small amount of breast tissue or fluid is removed from a suspicious area with a thin, hollow needle and checked for cancer cells during a fine needle aspiration (FNA). If other tests indicate that you may have breast cancer, this type of biopsy may be an option (although a core needle biopsy is often preferred). lt can also be used in other contexts. The main benefits of FNA are that it is relatively quick, it rarely requires anesthesia, the skin is not cut, so no stitches are required, and there is usually no scar. In some cases, one can even get the results on the same day.

Moreover, on 20th April 2020, The FDA-approved Fisher's CytoCore fine needle device, which can be attached to a small needle, has an internal motor that rotates the needle during the biopsy.

Geographical Analysis

North America region is expected to hold the largest market share in the global breast cyst treatment market

The growing incidence of breast cysts and increasing research and development in this region is expected to drive the market growth in the forecast period.

A palpable breast cyst is estimated to affect 7% of all women in the United States at some point in their lives. Breast cysts are most common in women aged 30 to 50. Moreover, key players in this region are expected to drive market growth. For instance, Becton, Dickinson, and Company, or BD, is a multinational medical technology company based in the United States. The company's FNA needles are available with a Chiba or Franseen tip for maximum versatility when aspirating soft tissue masses.

Competitive Landscape

The global breast cyst treatment market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Advin Health Care, Becton, Dickinson, and Company, Swastik Enterprise, Argon Medical Devices, Inc., SOMATEX Medical Technologies GmbH, Remington Medical Inc., HAKKO CO., LTD., BPB MEDICA

Becton, Dickinson, and Company

Overview: Becton, Dickinson, and Company, or BD, is a multinational medical technology company based in the United States that manufactures and sells medical devices, instrument systems, and reagents. In some areas, BD also offers consulting and analytics services.

Product Portfolio: The company's FNA needles are available with a Chiba or Franseen tip for maximum versatility when aspirating soft tissue masses.

Why Purchase the Report?

  • Visualize the composition of the global breast cyst treatment market segmentation by treatment type and end users highlighting the key commercial assets and players.
  • Identify commercial opportunities in global breast cyst treatment market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global breast cyst treatment market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global breast cyst treatment market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Breast Cyst Treatment Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Breast Cyst Treatment Market - Market Definition and Overview

3. Breast Cyst Treatment Market - Executive Summary

  • 3.1. Market Snippet By Treatment Type
  • 3.2. Market Snippet By End Users
  • 3.3. Market Snippet By Region

4. Breast Cyst Treatment Market -Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. The increasing research and development
    • 4.1.2. Restraints:
      • 4.1.2.1. Limitations associated with breast cyst treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Breast Cyst Treatment Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs

6. Breast Cyst Treatment Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Breast Cyst Treatment Market -By Treatment Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
  • 7.3. Market Attractiveness Index, By Treatment Type
    • 7.3.1. Fine Needle Aspiration*
      • 7.3.1.1.1. Introduction
      • 7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.3.2. Surgeries
    • 7.3.3. Radiotherapy
    • 7.3.4. Hormonal Therapy

8. Breast Cyst Treatment Market - By End Users

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 8.1.2. Market Attractiveness Index, By End Users
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Clinics
  • 8.4. Other

9. Breast Cyst Treatment Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

10. Breast Cyst Treatment Market - Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking

11. Breast Cyst Treatment Market - Company Profiles

  • 11.1. Becton, Dickinson and Company*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Advin Health Care
  • 11.3. Swastik Enterprise
  • 11.4. Argon Medical Devices, Inc.
  • 11.5. SOMATEX Medical Technologies GmbH
  • 11.6. Remington Medical Inc.
  • 11.7. HAKKO CO., LTD.
  • 11.8. BPB MEDICA

LIST NOT EXHAUSTIVE

12. Breast Cyst Treatment Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us